Clinical Trials Directory

Trials / Completed

CompletedNCT03808571

Cord Blood Nesfatin-1 and Irisin in the Intrauterine Growth Restricted Fetuses

The Association of Cord Blood Nesfatin-1 and Irisin Level With Fetal Doppler Parameters in Pregnancies Complicated With Intrauterine Growth Restricted Fetuses

Status
Completed
Phase
Study type
Observational
Enrollment
66 (actual)
Sponsor
Yuzuncu Yil University · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers

Summary

: The aim of this study is to investigate Cord blood irisin and nesfatin-1 levels in pregnancies with intrauterine growth retardation and to determine whether they are associated with abnormal fetal doppler findings or not.

Detailed description

This study was conducted at Yüzüncü Yıl University Medical Faculty Obstetrics and Gynecology Clinic. The study group included 34 pregnant women ranged from 18 to 45 years old who have intrauterine growth retardation and underwent ceseraen section. 32 pregnant women who had no abnormality on prenatal follow-up and underwent elective ceserean seciton served as control group. The maternal age, height, weight, body mass index (BMI), systolic and diastolic blood pressures were recorded in both groups of patients. Maternal serum total blood count and biochemical parameters were obtained from the laboratory parameters. Gestational week at birth, birth weight, sex, 1st and 5th minute APGAR scores were recorded. Blood samples were collected from all the cases during the cesarean section for measurmenet of nesfatin-1 and irisin by doubly clamped umbilical cord. Blood samples were immediately centrifuged in sterile tubes and maintained at -80 ° C until assessed.

Conditions

Interventions

TypeNameDescription
OTHERcord blood specimen during the deliveryThe cord blood will be taken during the delivery of baby.

Timeline

Start date
2018-01-01
Primary completion
2019-01-10
Completion
2019-01-15
First posted
2019-01-17
Last updated
2019-01-22

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT03808571. Inclusion in this directory is not an endorsement.